CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.

[1]  M. Meyerson,et al.  Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke , 2015, Head & neck.

[2]  D. Elashoff,et al.  Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. , 2014, American journal of otolaryngology.

[3]  M. Grimm,et al.  GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

[4]  R. Gibbs,et al.  Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers , 2014, Clinical Cancer Research.

[5]  Nadarajah Vigneswaran,et al.  Epidemiologic trends in head and neck cancer and aids in diagnosis. , 2014, Oral and maxillofacial surgery clinics of North America.

[6]  Angela N. Brooks,et al.  SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. , 2014, The Journal of clinical investigation.

[7]  Liangfang Shen,et al.  Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma. , 2014, International journal of clinical and experimental pathology.

[8]  E. Yi,et al.  Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell‐like cells , 2013, Proteomics.

[9]  E. Elkord,et al.  Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity , 2012, Clinical & developmental immunology.

[10]  P. Hainaut,et al.  TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression , 2011, Oncogene.

[11]  E. Sabo,et al.  Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[12]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[13]  D. Hayes,et al.  Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Godfrey,et al.  Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer , 2011, Clinical Cancer Research.

[15]  H. Vogel,et al.  ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. , 2011, Cell stem cell.

[16]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[17]  F. Hoebers,et al.  CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer , 2010, Clinical Cancer Research.

[18]  T. Salo,et al.  Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). , 2010, Oral oncology.

[19]  A. Carvalho,et al.  Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma , 2010, Molecules.

[20]  M. Tainsky,et al.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities. , 2009, Biochimica et biophysica acta.

[21]  D. Hayes,et al.  Never‐smokers, never‐drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancers , 2009, Head & neck.

[22]  C. Pan,et al.  EMMPRIN expression in tongue squamous cell carcinoma. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[23]  S. Warnakulasuriya.  Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[24]  P. Hainaut,et al.  p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity? , 2009, Cellular and Molecular Life Sciences.

[25]  M. Gillison,et al.  Human papillomavirus in HNSCC: recognition of a distinct disease type. , 2008, Hematology/oncology clinics of North America.

[26]  B. Mack,et al.  CD44s and CD44v6 Expression in Head and Neck Epithelia , 2008, PloS one.

[27]  J. Luo,et al.  Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma , 2008, British Journal of Cancer.

[28]  Jin-Ming Yang,et al.  Interaction between CD147 and P-Glycoprotein and Their Regulation by Ubiquitination in Breast Cancer Cells , 2008, Chemotherapy.

[29]  M. Slomiany,et al.  Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[30]  A. Forastiere,et al.  Head and neck cancer: changing epidemiology, diagnosis, and treatment. , 2008, Mayo Clinic proceedings.

[31]  D. Raben,et al.  Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma , 2008, Cancer.

[32]  M. Kogo,et al.  Tumor Thickness and Paralingual Distance of Coronal MR Imaging Predicts Cervical Node Metastases in Oral Tongue Carcinoma , 2008, American Journal of Neuroradiology.

[33]  M. Greene,et al.  CD147 immunoglobulin superfamily receptor function and role in pathology. , 2007, Experimental and molecular pathology.

[34]  G. de Rosa,et al.  OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome , 2007, British Journal of Cancer.

[35]  J. Myers,et al.  Metastasis of squamous cell carcinoma of the oral tongue , 2007, Cancer and Metastasis Reviews.

[36]  H. Lehr,et al.  Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. , 2007, Oral oncology.

[37]  Jin-Ming Yang,et al.  Involvement of CD147 in regulation of multidrug resistance to P‐gp substrate drugs and in vitro invasion in breast cancer cells , 2007, Cancer science.

[38]  R. Pazdur,et al.  Cancer Management: A Multidisciplinary Approach , 2007 .

[39]  F. McKeon,et al.  p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.

[40]  N. Philp,et al.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. , 2007, Cancer research.

[41]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[42]  S. Fulda,et al.  Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance , 2007, Oncogene.

[43]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[44]  Jing Lin,et al.  A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. , 2006, Cancer research.

[45]  K. Tsuneyama,et al.  Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis , 2006, British Journal of Cancer.

[46]  Jean Wu,et al.  Increased EMMPRIN (CD 147) expression during oral carcinogenesis. , 2006, Experimental and molecular pathology.

[47]  Phillip A. Sharp,et al.  Regulation of CD44 Alternative Splicing by SRm160 and Its Potential Role in Tumor Cell Invasion , 2006, Molecular and Cellular Biology.

[48]  M. Carrozzo,et al.  Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: A review of the literature , 2005, Head & neck.

[49]  C. Isacke,et al.  Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding , 2005, Journal of Cell Science.

[50]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[51]  B. Wollenberg,et al.  Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer. , 2005, Anticancer research.

[52]  R. Wyman,et al.  Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture , 2005, Journal of Cell Science.

[53]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[54]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[55]  F. Carinci,et al.  p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. , 2005, Human pathology.

[56]  Li Yan,et al.  Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression , 2005, Thrombosis and Haemostasis.

[57]  M. Urashima,et al.  CD147 and matrix metalloproteinase‐2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma , 2004, Cancer.

[58]  U. Moll,et al.  p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.

[59]  G. Frezza,et al.  Pattern of p63 expression in squamous cell carcinoma of the oral cavity , 2004, Virchows Archiv.

[60]  Rongsong Li,et al.  Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan Production , 2004, Cancer Research.

[61]  K. Nakashiro,et al.  Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. , 2003, Cancer letters.

[62]  R. Tanaka,et al.  Non-contrast-enhanced CT findings of high attenuation within metastatic cervical lymph nodes in patients with stage I or II tongue carcinoma during a follow-up period. , 2003, AJNR. American journal of neuroradiology.

[63]  E. Rosenthal,et al.  Expression of Extracellular Matrix Metalloprotease Inducer in Laryngeal Squamous Cell Carcinoma , 2003, The Laryngoscope.

[64]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Kanekura,et al.  Basigin (cd147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts , 2002, International journal of cancer.

[66]  Rudolf M. Huber,et al.  Combined transcriptome and genome analysis of single micrometastatic cells , 2002, Nature Biotechnology.

[67]  Guo-Pei Yu,et al.  Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[68]  B. Toole,et al.  Tumorigenic potential of extracellular matrix metalloproteinase inducer. , 2001, The American journal of pathology.

[69]  K. Pitman,et al.  More Aggressive Behavior of Squamous Cell Carcinoma of the Anterior Tongue in Young Women , 2000, The Laryngoscope.

[70]  J. Myers,et al.  Cancer of the oral cavity. , 2000, Current problems in surgery.

[71]  W. Zacharias,et al.  Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. , 2000, Human Pathology.

[72]  P. Hall,et al.  Characterization of the expression pattern of p63α and δnp63α in benign and malignant oral epithelial lesions , 2000 .

[73]  N H Terry,et al.  Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? , 1998, Head & neck.

[74]  A. Yuen,et al.  Elective neck dissection versus observation in the treatment of early oral tongue carcinoma , 1997, Head & neck.

[75]  J. Johnson,et al.  Effectiveness of selective neck dissection for management of the clinically negative neck. , 1997, Archives of otolaryngology--head & neck surgery.

[76]  Y. Hasegawa,et al.  Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma , 1997, Head & neck.

[77]  B. Asselain,et al.  Nodal failures in patients with N0 N+ oral squamous cell carcinoma without capsular rupture , 1996, Head & neck.

[78]  A. Dietz,et al.  Tobacco and alcohol and the risk of head and neck cancer , 1992, The clinical investigator.

[79]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[80]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[81]  A. Borges,et al.  Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. , 1989, American journal of surgery.

[82]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[83]  J. Teichgraeber,et al.  The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. , 1984, Head & neck surgery.

[84]  T. Tot,et al.  Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. , 2012, Anticancer research.

[85]  T. Salo,et al.  Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). , 2010, Oral oncology.

[86]  J. Roh,et al.  The prognostic value of hypoxia markers in T2-staged oral tongue cancer. , 2009, Oral oncology.

[87]  R. Kramer,et al.  Tumor cell invasion and survival in head and neck cancer , 2005, Cancer and Metastasis Reviews.

[88]  E. Horwitz,et al.  Head and neck tumors , 2003 .

[89]  X. Li,et al.  Expression of emmprin by oral squamous cell carcinoma. , 2000, International journal of cancer.

[90]  P. Hall,et al.  Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. , 2000, International journal of cancer.

[91]  Ronit Vogt Sionov,et al.  CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.